GB0724360D0 - Method for preparing protein conjugates - Google Patents

Method for preparing protein conjugates

Info

Publication number
GB0724360D0
GB0724360D0 GBGB0724360.3A GB0724360A GB0724360D0 GB 0724360 D0 GB0724360 D0 GB 0724360D0 GB 0724360 A GB0724360 A GB 0724360A GB 0724360 D0 GB0724360 D0 GB 0724360D0
Authority
GB
United Kingdom
Prior art keywords
protein conjugates
preparing protein
preparing
conjugates
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0724360.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0724360.3A priority Critical patent/GB0724360D0/en
Publication of GB0724360D0 publication Critical patent/GB0724360D0/en
Priority to PCT/EP2008/067378 priority patent/WO2009077438A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0724360.3A 2007-12-14 2007-12-14 Method for preparing protein conjugates Ceased GB0724360D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0724360.3A GB0724360D0 (en) 2007-12-14 2007-12-14 Method for preparing protein conjugates
PCT/EP2008/067378 WO2009077438A1 (en) 2007-12-14 2008-12-12 Method for preparing protein conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0724360.3A GB0724360D0 (en) 2007-12-14 2007-12-14 Method for preparing protein conjugates

Publications (1)

Publication Number Publication Date
GB0724360D0 true GB0724360D0 (en) 2008-01-23

Family

ID=39016541

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0724360.3A Ceased GB0724360D0 (en) 2007-12-14 2007-12-14 Method for preparing protein conjugates

Country Status (2)

Country Link
GB (1) GB0724360D0 (en)
WO (1) WO2009077438A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2961435B1 (en) * 2013-02-28 2019-05-01 ImmunoGen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
CN115093484B (en) * 2022-06-27 2024-06-25 苏州乙水茉生物科技有限公司 MiPEP156a and hymexazol conjugate, and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022995A1 (en) * 1999-09-30 2001-04-05 Novo Nordisk A/S A method for preparing conjugates between an antigen and mucosal binding component
EP1229045A1 (en) * 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
DE10121982B4 (en) * 2001-05-05 2008-01-24 Lts Lohmann Therapie-Systeme Ag Nanoparticles of protein with coupled apolipoprotein E to overcome the blood-brain barrier and process for their preparation
DE102004011776A1 (en) * 2004-03-09 2005-11-03 Lts Lohmann Therapie-Systeme Ag Carrier system in the form of protein-based nanoparticles for the cell-specific accumulation of pharmaceutically active substances
US20070254311A1 (en) * 2006-04-26 2007-11-01 Cardiogenics Inc. Covalent modification and conjugation of luciferase

Also Published As

Publication number Publication date
WO2009077438A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
HK1210413A1 (en) Oligosaccharide protein conjugates
LT3118220T (en) Protein
HK1158628A1 (en) Process for preparing dihydropteridinone derivatives
HUE047058T2 (en) Lyophilization method
IL200351A0 (en) Method for preparing nano-emulsions
EP2050341A4 (en) Method for making lactose-removing milk
IL201391A0 (en) Method for stabilizing a protein
PL2213654T3 (en) Process for preparing 2-amino-5-bromobenzamide derivatives
IL205716A0 (en) Formulations for taci-immunoglobulin fusion proteins
PL1970396T3 (en) Method for preparing SIC-bound polyethersiloxanes
HRP20150775T1 (en) Method for preparing hypoallergens
EP2155792A4 (en) Protein g-oligonucleotide conjugate
EP2068904A4 (en) Methods for preparing diazonamides
HK1111160A1 (en) Process for preparing
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
EP2053926A4 (en) Process for preparing hybrid proteins
IL196142A0 (en) Process for preparing amidrazones
EP2183359A4 (en) Improved methods for protein production
GB0719231D0 (en) Protein
IL195262A0 (en) Process for preparing hydroxylpatite
GB0724357D0 (en) Method for preparing protein conjugates
GB0724360D0 (en) Method for preparing protein conjugates
GB0721991D0 (en) Preparation method
IL197022A0 (en) Novel preparation method
EP1976858A4 (en) Method for preparing 4-demethyldaunorubicin

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)